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Abstract
Immunocompromised patients who develop invasive filamentous mycotic infections can be efficiently treated if
rapid identification of the causative fungus is obtained. We report a case of fatal necrotic pneumonia caused by
combined pulmonary invasive mucormycosis and aspergillosis in a 66 year-old renal transplant recipient. Aspergillus
was first identified during the course of the disease by cytological examination and culture (A. fumigatus)o f
bronchoalveolar fluid. Hyphae of Mucorales (Rhizopus microsporus) were subsequently identified by culture of a tis-
sue specimen taken from the left inferior pulmonary lobe, which was surgically resected two days before the
patient died. Histological analysis of the lung parenchyma showed the association of two different filamentous
mycoses for which the morphological features were evocative of aspergillosis and mucormycosis. However, the
definitive identification of the associative infection was made by polymerase chain reaction (PCR) performed on
deparaffinized tissue sections using specific primers for aspergillosis and mucormycosis. This case demonstrates
that discrepancies between histological, cytological and mycological analyses can occur in cases of combined
mycotic infection. In this regard, it shows that PCR on selected paraffin blocks is a very powerful method for mak-
ing or confirming the association of different filamentous mycoses and that this method should be made available
to pathology laboratories.
Introduction
Invasive fungal infections appear to have increased over
the past few years, mostly in immunocompromised
patient [1-4]. Moreover, the diagnosis of invasive fila-
mentous fungal disease (IFFD) is often difficult in
immunodeficient patients. Tissue specimens are difficult
to obtain in debilitated patients, but are essential in
detecting invasive fungi [5]. In the absence of identifica-
tion of fungal elements in tissue, the diagnosis of a
“probable” invasive fungal disease (IFD) can be retained
when a host factor, clinical features and mycological evi-
dence are present [5]. Additionally, the diagnosis of a
“possible” IFD is made when appropriate host factors
and sufficient clinical evidence are present [5]. Since a
high level of mortality occurs in immunocomprised
patients with IFFD [6-8], an accurate and rapid diagno-
sis is required in order to give the appropriate anti-fun-
gal treatment. In addition, depending of the isolated
fungal species, some of these treatments can be ineffi-
cient [9,10]. The combination of two or more IFFD
occurring simultaneously or sequentially in immuno-
compromised patients makes diagnosis of these patients
very challenging. Combined invasive mucormycosis and
aspergillosis has been rarely described, its occurrence
has probably been underestimated [11-16]. Predisposing
factors and clinical features in association with these
mycoses are almost the same [17,18]. Although
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different species, combined infections are diagnosed
histologically.
We report a case of an associated aspergillosis and
mucormycosis infection responsible for fatal necrotic
and extensive pneumonia in a patient with a renal trans-
plant. Mycological analysis identified Aspergillus fumiga-
tus in a culture of bronchoalveolar lavage (BAL) and
Rhizopus microsporus in a culture of a lung tissue speci-
men. Identification of a combined aspergillosis and
mucormycois infection was made by PCR performed on
formaldehyde pulmonary fixed tissues.
Case report
A 66-year-old man, who had received a renal transplant
5 months before, and was on tritherapy [prednisolone (1
mg/kg/day); cyclosporine A (7 mg/kg/day); azathioprine
(1 mg/kg/day)], was admitted to the hospital with
hemoptysia. A computed tomographic scan of the chest
showed a not well-circumscribed and excavated mass
mass involving the pulmonary inferior left lobe, bilateral
pleural effusions, and a small parenchyma nodule in the
pulmonary inferior right lobe (Fig. 1A et 1B). An analy-
sis of the BAL was quickly performed due to the pre-
sence of Aspergillus fumigatus in sputum:
cytopathological examination showed filamentous
hyphae corresponding to aspergillosis (Fig. 1C). These
filaments were subsequently identified by culture as A.
fumigatus. In addition, pyocyanic bacteria were isolated
from the BAL. Treatment associating voriconazole, cef-
tazidime and ciprofloxacine was started. However, the
absence of a clinically improved status and repeated
massive hemoptysia, led to surgical resection of the pul-
monary left inferior lobe one week later. Gross macro-
scopy demonstrated a diffuse hemorrhagic infarct of the
lung (Fig. 1D). A specimen of lung tissue was sent to
the mycology laboratory. The patients died of cardio-
pulmonary failure two days after surgery.
Materials and methods
Histological study
Numerous specimens (more than thirty) were taken
from the surgical specimen, fixed in 10% formaldehyde
and paraffin embedded. 5 μm paraffin sections were
stained with haematoxylin eos i ns a f r a n( H E S ) ,p e r i o d i c
acid Schiff (PAS), Gomori Grocott’s methanamine silver
(GGM), Gram, Warthin-Starry, and Zielh-Neelsen
stains.
Molecular biology
Tissue sections were deparaffinized with xylene and
DNA was extracted from formalin fixed, paraffin
embedded tissue using QIAmp DNA Mini Kit (QIA-
GEN AG, Hombrechtikon, Switzerland) as described by
t h em a n u f a c t u r e r .T h ep r e s e n c eo fa d e q u a t eD N Aw a s
confirmed by amplifying the human beta-globin gene as
previously described [19]. Previously described specific
sequences of 5.8 sRNA and 18 sRNA of Aspergillus sp.
and mucor, respectively, were chosen as target
sequences with slight modification [20,21]. For the
detection of mucor, nested PCR was used with primers
described previously [20], but with modification:
Mucor1 (5’-WTTACC RTG AGC AAA TCA GA-3’)
and Mucor2 (5’-CAA TCY AAG AAT TTC ACC
TCTAG-3) for the first round and Mucor3 (5’-AGC
ATG GAA TAA TRA AAY A-3’)a n dM u c o r 4( 5 ’-AGC
ATG GGA TAA CGG AAT A-3) for the second round,
respectively, giving a final PCR product of 124 bp. For
the detection of Aspergillus, the following primers were
used as described [21], but with modification: AspNest1
(5’-TCTTGGTTCCGGCATCGAT-3) and AspNest2
(5’TGACAAAGCCCCATACGCT-3’) for the first round
and AspNest3 (5’-GAAGAACGCAGCGAAATGC-3’)
and AspNest4 (5’-AACACACAAGCCGTGCTTGA-3’)
for the second round, respectively, leading to a final
PCR product of 146 bp. The basic amplification reac-
tions were done as described before using a volume of
50 μl containing 100 to 500 ng of DNA, 2.5 ml of each
primer (final concentration 3 mM), 25 μlM a s t e rM i x
Gold (Applied Biosystems, Paris, France) [22]. Amplifi-
cation and detection were performed on the ABI 9800
Fast Thermal Cycler (Applied Biosystem) using for both
primer sets, the same cycling conditions with an initial
cycling step at 94°C for 10 minutes followed by 94°C,
55°C and 72°C for 30 seconds each ending at 4°C. Ten
microliters of each amplification product was analyzed
by electrophoresis in an ethidium bromide-containing
2% agarose gel. In addition, PCR products were
extracted from a low melting agarose gel and DNA
sequencing was performed to confirm the appropriate
DNA sequence. Stringent laboratory conditions and
appropriate negative and positive controls were per-
formed in each run.
Mycological analysis
The microscopic examination of the BAL was done in a
mixture of potassium hydroxide and chlorazole black E
and demonstrated septate and dichotomous branching
hyphae. A. fumigatus grew on Sabouraud’s glucose agar
at 28°C. The strain was tested against voriconazole with
the E-test method and showed a good sensitivity [Mini-
mum Inhibit Concentration = 0.125 μg/ml]. The direct
examination of the per operative pulmonary biopsy
showed non-septate right-angled -branching hyphae
suggestive of Mucorales.
Results
Pathological findings
All tissue sections stained with HES showed large areas
of infarct associated with a few neutrophils, histiocytes
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congestive or thrombotic. Most of these blood vessels
were invaded by large hyphae, measuring from 30 to 50
μm in their largest diameter (Fig. 2A). GGM staining
confirmed the presence of numerous fungal elements
indicative of a mucormycosis infection: presence of
broad-based non septated hyphae with branching at
right angles, or twisted hyphae (Fig. 2B). The hyphae
were faintly stained with PAS. In a few areas, two differ-
ent subtypes of hyphae were found in association: first
some hyphae were identical to those described above,
and second some thinner septated hyphae, 8 to 12 μm
in diameter, regular, sometimes branching at acute
angles, which could correspond to aspergillosis (Fig.
2C). These filaments invaded blood vessels. Numerous
bacteria were observed on HES and Gram staining (Fig.
2C). Other stains gave negative results.
PCR analysis from deparaffinized sections performed
from a selected paraffin block showing both subtype of
hyphae, allowed identification of aspergillosis and
mucormycosis (Fig. 2D). DNA sequencing of the PCR
products were performed and showed a 100% concor-
dance with Aspergillus sp. and Rhizopus sp. (namely Rhi-
zopus microsporus) for the apergillus and mucor PCR,
respectively.
Figure 1 A and B: CT scan showing a large excavated pulmonary mass of the pulmonary left inferior lobe, outlined by a glassy
feature and associated with pleural effusion (A. Non injected CT scan; B Injected CT scan). C. Mycotic filaments showing the
morphological features of aspergillosis isolated from the BAL (Gomori-Grocott silver method × 1000). D. Gross macroscopy of the resected
pulmonary lobe showing a hemorrhagic infarct.
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Culture on Sabouraud’sd e x t r o s ea g a ra t2 8 ° Cy i e l d e da
fast-growing mold (3 days). Colonies were woolly and
initially white, quickly become grayish brown. The fun-
gus was identified as Rhizopus microsporus var. rhizopo-
diformis on the basis of morphological features: rhizoids
and sporangiophores of 400 μm in length and in groups
o f1t o4 ;s p o r a n g i as p h e r i c a lo fa p p r o x i m a t e l y1 0 0μm
grayish black; spherical sporangiospores (5 μm) fine spi-
nulose and the capacity to grow at 50°C (Fig. 3A-C).
The morphological identification was confirmed by
sequencing the whole ITS1-5.8S-ITS2 region [23]. Anti-
fungal sensitivity testing using the EUCAST method
showed a decreased susceptibility to the voriconazole
(MIC = 8 μg/ml); and a MIC that was considered to be
within the sensitivity range to amphotericin B (MIC =
0.06 μg/ml) and posaconazole (MIC = 0.5 μg/ml).
Discussion
Although invasive mycoses have long been recognized
for a long time as being caused by significant pathogens,
particularly in immunocompromised patients, the fre-
quency of infection with opportunistic fungi is increas-
ing with time and the spectrum of the infectious agent
of invasive mycoses is changing [1-4]. In this regard,
advances in therapeutic technologies and in particular
the development of novel immunosuppressive therapies,
have prolonged the period of risk for many individuals
[3,4]. A large number of invasive mycoses have been
identified because of the increase in the number of
patients at risk [24-26]. Most of the invasive mycoses
are caused by filamentous fungi, rarely by other fungi
[6,27-29]. In this regard, a number of IFFD has been
reported in renal transplant patients, particularly asper-
gillosis and mucormycosis [30]. Other IFFD have been
Figure 2 A. Hyphae with a large diameter invading blood vessels (HES, original magnification, × 400). B. Morphological features of
mucorales (Gomori-Grocott silver method, original magnification × 1000). C. Association of two different hyphae in the same tissue section
showing morphological feature of mucorales (arrowhead) and of aspergillosis (arrow). Asteriks: associated bacteria (HES, original magnification, ×
800). D. Molecular biology a: PCR of Aspergillus b: PCR of Mucor: M: Marker, neg: negative controls, pos: positive controls.
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such as scedosporiosis [31].
Ac o n f i r m e dd i a g n o s i so fI F F Di sm a d eo nt h e
demonstration of hyphae in the diseased tissue. Patholo-
gical identification of the hyphae is based on different
well-described criteria: diameter, presence of septa, and
branching angle (right or acute branching), pigmenta-
tion [32,33]. It is important to consider the characteris-
tics of the infiltrate at the inflammatory region that is in
contact with hyphae: presence of angioinvasion, of giant
cells and of eosinophilic necrosis [34]. Mycological ana-
lysis made on non fixed-tissue specimens, associating
microscopic examination and culture allows identifica-
tion of the species and the study of the sensitivity to
anti-fungal drugs. However, the different results of these
mycological analyses can be negative in the following
circumstances: 1) When there is an error in sampling,
the specimen sent to the mycology laboratory does not
contain the different fungi, 2) When the specimen con-
taining the hyphae is totally necrotic. In addition, when
two filamentous mycoses are present in the same organ,
the mycological results are even more inconstant, since
only one fungus might be present on the specimen sent
to the mycology laboratory. In these different situations,
it is essential to compare the culture results and the
morphological analysis of the tissue sections. However,
histological analyses have some limits, even after histo-
chemical staining.
The distinction between aspergillosis and scedosporio-
sis, between aspergillosis and fusariosis and certain
mucormycosis, such as those caused by Cunninghamella
from tissue sections may be difficult or impossible
[31,35,36]. Other potential pitfalls are more easily elimi-
nated [37,38]. Ancillary methods using specific antibo-
dies raised against filamentous fungi can be helpful for
diagnosis. However, the different antibodies are rarely
commercially available [33,36,39]. Finally, in situ hybri-
dization has been developed for fungal detection in
fixed-tissue sections, but the probes used for this
method are rarely available in the pathology laboratory
[40]
In recent years, PCR methods performed with deparaf-
finized tissue sections have been used to try to improve
the detection and identification of pathogens in fixed
specimens [39,41]. This methodology needs to use strict
positive and negative controls and exact comparison
with histological features and mycological analysis is
required. However, false-negative and false-positive
results due to artefacts in amplification, or sampling,
and possible exogenous contamination by microorgan-
isms, still are very important pitfalls in molecular diag-
nostic pathology [42,43]. In the present case, there was
no evidence of contamination by external sources and
Figure 3 A. Stereomicroscopic image of the habit sketch of
Rhizopus microsporus var rhizopodiformis. B. Micromorphology
showing the dark brown unbranched sporangiophores born directly
from rhizoids. C. Finely roughened (sub) spherical sporangiospores
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over and false positive results.
The present case report underlines the usefulness of
the PCR method performed with embedded paraffin
fixed specimens, which allows simultaneous detection
on the same tissue of two types of IFFD. Moreover, the
pathogenic status of these pathogens can be confirmed
by comparing histopathological and molecular biology
r e s u l t so b t a i n e df r o mt h es a m ee m b e d d e dp a r a f f i nt i s -
sue. In the present case, the absence of mycological
diagnosis of aspergillosis from non-fixed biopsy speci-
men was probably due to an error in sampling. In this
regard, histological analysis showed only a few areas
with the two associated mycoses. Filaments of aspergil-
losis, but not of mucorales, were noted by cytopatholo-
gical analysis of the BAL and identified as A. fumigatus
in culture. This can be due to an error in sampling, but
also because at that time mucorales was undetectable,
since it grew subsequently in the patient treated with
voriconazole. However, the clinical distinction between
aspergillosis and mucormycosis is crucial since there is
an increased incidence of mucormycosis in patients
treated with voriconazole for suspected aspergillosis
[44]. In this regard, a couple of cases of mucormycosis
occurring in patients with voriconazole-treated aspergil-
losis have been reported [9,44]. The diagnosis of IFFD
based on hyphae isolated from the BAL is uncertain. In
this case, different associated clinical features and pre-
disposing host factors must be present before giving
specific treatment, which can be toxic, ineffective, and
favor the development of another mycotic disease
[45,46]. Finally, for most clinicians, the identification of
aspergillosis or mucormycosis in the BAL is not suffi-
cient to confirm the diagnosis of IFFD [47]. The utility
of performing transbronchial or transparietal biopsies in
debilitated patients should be discussed [48,49].
Conclusion
Our observations outline the difficulty of diagnosing
associated invasive mycoses in immunocompromised
patients. For diagnosis, it is crucial to compare the his-
tological and mycological analyses. However, as demon-
strated here, molecular biology performed on FFPE
tissue sections, after morphological control on a mir-
rored stained tissue section, can be the only method for
the identification of different pathogens in case of dis-
crepancies between pathological and mycological
approaches. In this regard, we strongly believe that
molecular biology of FFPE tissues should be developed
and available to surgical pathology laboratories for infec-
tious diseases pathology, since, in particular in immuno-
compromised patients, it is crucial in cases of invasive
mycotic diseases to provide a rapid and optimal
treatment
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